• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过定量PCR测定rSAG-1(P30)免疫对豚鼠循环和组织寄生虫的影响。

Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR.

作者信息

Flori Pierre, Tardy Laëtitia, Jacquet Alain, Bellete Bahrie, Hafid Jamal, Raberin Hélène, Tran Manh Sung Roger

机构信息

Laboratoire de Parasitologie-Mycologie, C.H.U. de Saint Etienne, Hôpital Nord, 42055, Saint-Etienne, cedex 2, France.

出版信息

Parasitol Res. 2006 May;98(6):511-8. doi: 10.1007/s00436-005-0074-y. Epub 2006 Jan 17.

DOI:10.1007/s00436-005-0074-y
PMID:16416293
Abstract

The efficacy of immunisation with Toxoplasma gondii recombinant protein (rSAG-1) was evaluated in the guinea pig model. For the infectious challenge, two strains, namely, strain C56 (10,000 tachyzoites) and strain 76K (100 cysts), were used to infect a group of 32 guinea pigs each. The circulating, cerebral and pulmonary parasite loads were determined with the real-time polymerase chain reaction (PCR) after immunisation. With the C56 strain, immunisation showed high activity with a reduction of greater than 1 log of the circulating and tissue parasite loads. Thus, there was a significantly lower circulating parasite load in the rSAG-1 + adjuvant group (0.5+/-1.5 Eq parasites/ml) as compared to that in the control group (67+/-110 Eq parasites/ml; p<0.05). In the same manner, the cerebral parasite load was much lower in the rSAG-1 + adjuvant group (10+/-20 Eq parasites/g) than that in the control group (339+/-291 Eq parasites/g; p<0.01). On the other hand, with the 76K strain, the effect of immunisation was much less and that only on the pulmonary parasite load [p(lung)<0.05]. This could be due to the use of different strains and stages of the parasite and/or the difference in the route of administration for challenge. The quantitative PCR technique used has shown a good correlation with animal inoculation, and when associated with the guinea pig model, it seems to be a useful and reproducible technique for future vaccine studies.

摘要

在豚鼠模型中评估了弓形虫重组蛋白(rSAG-1)免疫的效果。对于感染性攻击,使用两株菌株,即C56株(10,000个速殖子)和76K株(100个包囊)分别感染一组32只豚鼠。免疫后通过实时聚合酶链反应(PCR)测定循环、脑和肺中的寄生虫负荷。对于C56株,免疫显示出高活性,循环和组织寄生虫负荷减少超过1个对数。因此,与对照组(67±110 Eq寄生虫/ml)相比,rSAG-1+佐剂组的循环寄生虫负荷显著更低(0.5±1.5 Eq寄生虫/ml;p<0.05)。同样,rSAG-1+佐剂组的脑寄生虫负荷(10±20 Eq寄生虫/g)比对照组(339±291 Eq寄生虫/g;p<0.01)低得多。另一方面,对于76K株,免疫效果要小得多,且仅对肺寄生虫负荷有影响[p(肺)<0.05]。这可能是由于使用了不同的寄生虫菌株和阶段和/或攻击给药途径的差异。所使用的定量PCR技术已显示与动物接种有良好的相关性,并且与豚鼠模型结合时,它似乎是未来疫苗研究中一种有用且可重复的技术。

相似文献

1
Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR.通过定量PCR测定rSAG-1(P30)免疫对豚鼠循环和组织寄生虫的影响。
Parasitol Res. 2006 May;98(6):511-8. doi: 10.1007/s00436-005-0074-y. Epub 2006 Jan 17.
2
Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.评价三种由弓形虫表面和分泌抗原组成的重组多抗原疫苗在实验性弓形虫病小鼠模型中的效果。
Vaccine. 2011 Jan 17;29(4):821-30. doi: 10.1016/j.vaccine.2010.11.002. Epub 2010 Nov 16.
3
Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.在一种新型的对刚地弓形虫易感的小鼠模型(A/Sn)中对速殖子排泄-分泌蛋白免疫接种的评估。
Exp Parasitol. 2008 Nov;120(3):227-34. doi: 10.1016/j.exppara.2008.07.015. Epub 2008 Jul 31.
4
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.评估单磷酰脂质A(MPL)佐剂配制的重组致密颗粒抗原GRA2和GRA6对小鼠弓形虫慢性感染的保护作用。
Vaccine. 2007 May 22;25(21):4301-11. doi: 10.1016/j.vaccine.2007.02.057. Epub 2007 Mar 9.
5
Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice.刚地弓形虫:表达GRA1和MIC3的DNA疫苗诱导BALB/c小鼠对弓形虫病的保护性免疫。
Exp Parasitol. 2016 Jul;166:131-6. doi: 10.1016/j.exppara.2016.04.003. Epub 2016 Apr 6.
6
Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.刚地弓形虫:重组棒状体蛋白2和棒状体蛋白4在小鼠实验性弓形虫病中的免疫原性和保护效力
Exp Parasitol. 2009 Sep;123(1):81-9. doi: 10.1016/j.exppara.2009.06.002. Epub 2009 Jun 7.
7
Quantification of Toxoplasma gondii in the tissues of BALB/c mice after immunization with nanoliposomal excretory-secretory antigens using Real-Time PCR.使用实时荧光定量PCR技术对用纳米脂质体排泄分泌抗原免疫后的BALB/c小鼠组织中的弓形虫进行定量分析。
Comp Immunol Microbiol Infect Dis. 2018 Aug;59:52-56. doi: 10.1016/j.cimid.2018.09.012. Epub 2018 Sep 23.
8
Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.弓形虫蛋白酶抑制剂-1(TgPI-1)是一种新型的抗弓形虫病疫苗候选物。
Vaccine. 2008 Sep 15;26(39):5040-5. doi: 10.1016/j.vaccine.2008.07.031. Epub 2008 Aug 21.
9
Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.用减毒活重组鼠伤寒沙门氏菌进行口服免疫可保护小鼠免受刚地弓形虫感染。
Parasite Immunol. 2005 Jan-Feb;27(1-2):29-35. doi: 10.1111/j.1365-3024.2005.00738.x.
10
The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.刚地弓形虫毒力相关的 rhoptry 蛋白 5(ROP5)是一种针对小鼠弓形虫病的新型疫苗候选物。
Vaccine. 2013 Sep 23;31(41):4578-84. doi: 10.1016/j.vaccine.2013.07.058. Epub 2013 Aug 5.

本文引用的文献

1
Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.评估携带与GM-CSF质粒相关的编码抗原GRA4和SAG1的基因的DNA疫苗对小鼠急性、慢性和先天性弓形虫病的保护作用。
Vaccine. 2005 Aug 22;23(36):4489-99. doi: 10.1016/j.vaccine.2005.04.025.
2
Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.重组GRA4或ROP2蛋白与明矾或gra4基因联合使用,在弓形虫病慢性小鼠模型中提供了部分保护作用。
Clin Diagn Lab Immunol. 2004 Jul;11(4):704-10. doi: 10.1128/CDLI.11.4.704-710.2004.
3
Simple technique for internal control of real-time amplification assays.
Clin Chem. 2004 May;50(5):819-25. doi: 10.1373/clinchem.2003.027961. Epub 2004 Mar 9.
4
Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2.嵌合蛋白rSAG1/2诱导小鼠对刚地弓形虫的保护性免疫
Parasitol Res. 2004 Jan;92(1):58-64. doi: 10.1007/s00436-003-0992-5. Epub 2003 Nov 6.
5
Comparison of PCR-enzyme-linked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient.聚合酶链反应-酶联免疫吸附测定法与实时聚合酶链反应测定法在诊断干细胞移植受者罕见脑弓形虫病病例中的比较。
J Clin Microbiol. 2003 Nov;41(11):5313-6. doi: 10.1128/JCM.41.11.5313-5316.2003.
6
Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice.用弓形虫SAG-1蛋白进行疫苗接种对BALB/c小鼠的先天性弓形虫病具有保护作用,但对CBA/J小鼠则没有。
Infect Immun. 2003 Nov;71(11):6615-9. doi: 10.1128/IAI.71.11.6615-6619.2003.
7
Influence of the quantity of nonspecific DNA and repeated freezing and thawing of samples on the quantification of DNA by the Light Cycler.非特异性DNA的量以及样品反复冻融对Light Cycler定量DNA的影响。
J Microbiol Methods. 2003 Oct;55(1):213-9. doi: 10.1016/s0167-7012(03)00141-6.
8
Parasite load in guinea pig foetus with real time PCR after maternofoetal transmission of Toxoplasma gondii.在弓形虫母婴传播后,用实时聚合酶链反应检测豚鼠胎儿中的寄生虫负荷。
Parasite. 2003 Jun;10(2):133-40. doi: 10.1051/parasite/2003102133.
9
Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes.用弓形虫热休克蛋白70、热休克蛋白30和表面抗原1基因进行DNA疫苗接种诱导保护性免疫
Vaccine. 2003 Jun 20;21(21-22):2852-61. doi: 10.1016/s0264-410x(03)00157-9.
10
DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission.
Vaccine. 2003 Jun 20;21(21-22):2813-20. doi: 10.1016/s0264-410x(03)00163-4.